Answers are grounded in this paper and cite their sources.
Peptidyl‐prolyl cis/trans isomerase NIMA‐interacting 1 (PIN1) is a phosphorylation‐specific prolyl isomerase implicated in multiple oncogenic signaling pathways. Aberrant overexpression of PIN1 has been observed in various human cancers and is associated with tumor progression and poor clinical outcomes. Although several PIN1 inhibitors, such as sulfopin, have been reported, their development as therapeutic agents remains challenging, partly due to limitations in cellular activity. In this study, we developed sulfopin‐based PIN1‐targeting hydrophobic tagging (HyT) degraders and identified adamantane‐containing compound 9 (IC 50 = 6.08 μM) as the most active hit in MCF‐7 cells following the evaluation of different hydrophobic tags and linker structures, with markedly improved anticancer activity relative to sulfopin. Compound 9 induced concentration‐dependent PIN1 degradation (DC 50 = 6.61 μM), which was rescued by MG132, indicating a proteasome‐dependent mechanism. Compound 9 also induced caspase‐7‐associated apoptotic cell death in MCF‐7 cells and exhibited anticancer activity across multiple cancer cell models. SwissADME analysis further suggested that compound 9 possesses favorable predicted physicochemical and ADME properties compared with reported PIN1‐targeting PROTAC degraders. Collectively, these findings support sulfopin‐based HyT degradation as a promising complementary approach for the development of PIN1‐targeted anticancer degraders.
No takes yet. Share an insight, caveat, or question.
Seo et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: